This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Menu
Close
The content of this website has been produced in line with the BESPONSA®▼ (inotuzumab ozogamicin) Summary of Product Characteristics for Great Britain and is intended for Healthcare Professionals based in Great Britain. BESPONSA Prescribing Information for Great Britain click here. BESPONSA Prescribing Information for Northern Ireland click here. Adverse event reporting information can be found at the bottom of the page.
Collaborators: Michelle Kenyon, Consultant Nurse (BMT) & Dr Daniele Avenoso, Consultant Haematologist from Kings College Hospital NHS Foundation Trust
Log in/register to watch Michelle Kenyon and Dr Daniele Avenoso from King's College Hospital NHS Foundation Trust discuss a new model of care which is a standardised and systematic approach to the screening, assessment and diagnosis of veno-occlusive disease (VOD).
Watch Michelle Kenyon and Dr Daniele Avenso from King's College Hospital NHS Foundation Trust discuss a new model of care which is a standardised and systematic approach to the screening, assessment and diagnosis of veno-occlusive disease (VOD).
Michelle Kenyon is a Consultant Nurse in haematopoietic stem cell transplantation, whose interests focus on improving the patient and caregiver experience during haematopoietic stem cell transplantation and supporting patients throughout their post-transplant recovery. Her research and service development interests centre on patient experience, psychosocial issues, treatment consequences and the unmet needs of those living with and beyond their diagnosis. Her role also enables her to lead a team and teach regularly. As current President of the European Blood and Marrow Transplant (EBMT) Nurses’ Group, she has a strong commitment to delivering education for nurses both nationally and internationally to benefit patient care. Michelle has authored two patient information books, which are used as the basis for informed consent for transplant recipients throughout the UK, and she is Co-editor of the first EBMT Textbook for Nurses, the second edition of which was published in 2023.
Dr Daniele Avenoso is a consultant haematologist in stem cell transplantation at King’s College Hospital. After his medical degree in Genoa (Italy) in 2011 at University of Genoa, he started his specialty training in haematology at the same University and obtained his CCT in 2017. He spent a year of his specialty training at Hammersmith Hospital in London (UK). Since 2017 he worked as stem cell transplant consultant in Italy, and he moved to King’s College Hospital in 2019 accepting a consultant position in BMT and ambulatory care. In 2020 he obtained his PhD in translation haematology (research project in miRNA and MDS). He is a member of the ALWP and CMWP of the EBMT and is interested in clinical trials in transplantation. His research area focuses on GVHD, alternative donors and new conditioning regimens.
VOD, veno-occlusive disease
This material is intended for UK healthcare professionals only and has been developed and funded by Pfizer in collaboration with Michelle Kenyon, Consultant Nurse and Dr Daniele Avenoso, Consultant Haematologist, from King's College Hospital.
Download an infographic summary outlining how King's College Hospital successfully implemented a dedicated ward round to assess and diagnose VOD.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024